Early anatomical outcomes of faricimab vs aflibercept 2 mg in treatment-naïve neovascular age-related macular degeneration and polypoidal choroidal vasculopathy: A head-to-head comparative study in Taiwan. [PDF]
Yang CC +6 more
europepmc +1 more source
Efficacy and Safety of Ophthalmic Steroids in the Management of Polypoidal Choroidal Vasculopathy: A Systematic Review. [PDF]
Adriono GA +6 more
europepmc +1 more source
Intravitreal Aflibercept With vs Without Pneumatic Displacement for Submacular Hemorrhage Associated With Polypoidal Choroidal Vasculopathy. [PDF]
Wakabayashi T +10 more
europepmc +1 more source
Faricimab efficacy in a poorly responsive case of Polypoidal Choroidal Vasculopathy (PCV): A case report. [PDF]
Rizzo C +3 more
europepmc +1 more source
SUBRETINAL PIGMENT EPITHELIUM OPTICALLY EMPTY STRUCTURES IN POLYPOIDAL CHOROIDAL VASCULOPATHY: A Novel Optical Coherence Tomography Finding. [PDF]
Teo KYC, Chong YJ, Cheung CMG.
europepmc +1 more source
Polypoidal choroidal vasculopathy with an exceptionally elevated pigment epithelial detachment. [PDF]
Li Y, Gabr H, Mieler WF.
europepmc +1 more source
Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy. [PDF]
Liu Y, Guo J, Tang W, Xu G, Liu W.
europepmc +1 more source
Comparative Efficacy of Brolucizumab and Aflibercept in Polypoidal Choroidal Vasculopathy: A Systematic Review and Meta-Analysis. [PDF]
Allehyani MH +10 more
europepmc +1 more source
Preferential Locations of Polypoidal Lesions and Adjacent Pigment Epithelium Detachments in Polypoidal Choroidal Vasculopathy in a Japanese Population. [PDF]
Kogo T +11 more
europepmc +1 more source
Usage of brolucizumab as treatment for wet age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV): A narrative review. [PDF]
Jezani SN, Bastion MC.
europepmc +1 more source

